Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study

Autor: Reid, Tony, Oronsky, Bryan, Scicinski, Jan, Scribner, Curt L, Knox, Susan J, Ning, Shoucheng, Peehl, Donna M, Korn, Ron, Stirn, Meaghan, Carter, Corey A, Oronsky, Arnold, Taylor, Michael J, Fitch, William L, Cabrales, Pedro, Kim, Michelle M, Burris, Howard A, 3rd, Lao, Christopher D, Abrouk, Nacer E D, Fanger, Gary R, Infante, Jeffrey R
Zdroj: In The Lancet Oncology September 2015 16(9):1133-1142
Databáze: ScienceDirect